LanzaTech Global (LNZA) said late Tuesday it expects to reduce 10% to 15% of its global workforce in a bid to cut costs.
The company expects the initiative to help it achieve roughly $30 million of annual cash operating expense reductions, it said.
LanzaTech is assessing scale up opportunities for its nutritional protein capabilities, along with its recently outlined plan to spin out its synthetic biology platform.
The company said it has rescheduled its Q4 and 2024 earnings call to March 31.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.